Blog Posts - Sofosbuvir



Wider access to hepatitis C drugs is humane and pragmatic

Wider access to hepatitis C drugs is humane and pragmatic  Boston Globe The long-term health prospects for thousands of Massachusetts residents are about to improve. As of Monday, MassHealth... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jul 29, 2016

UK health service under fire over access to hepatitis C drugs

Feature Investigation A pill too hard to swallow: how the NHS is limiting access to high priced drugs (Published 27 July 2016) Cite this as: BMJ 2016;354:i4117 A joint investigation by The BMJ and... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jul 28, 2016

New Poll - 64 Percent of Global Doctors Believe New Hepatitis C Drugs Are Worth the Cost

New Poll Finds 64 Percent of Global Doctors Believe New Hepatitis C Drugs Are Worth the Cost July 21, 2016 01:46 PM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--In advance of World... Monday HCV News Ticker- Hepatitis C: Coffee, Medica...
by HCV New Drug Research on Jul 21, 2016

TGIF Rewind - HCV Medications Blog; Genotype, cure rates, side effects, and drug interactions

To The People Of France My family and I wish to convey our solidarity and sorrow to the citizens of France today. May we offer our sincere condolences to the victims families who were injured and... Monday HCV News Ticker- Hepatitis C: Coffee, Medic...
by HCV New Drug Research on Jul 15, 2016

Gilead receives approval in Canada for EPCLUSA™ (sofosbuvir/velpatasvir)

Gilead receives approval in Canada for EPCLUSA™ (sofosbuvir/velpatasvir), the first once-daily pan-genotypic (genotypes 1-6) single tablet regimen for the treatment of chronic hepatitis C -- 12-Week... Monday HCV News Ticker- Hepatitis C: Coffee,...
by HCV New Drug Research on Jul 14, 2016

Watch: 2016 Newly Approved Hepatitis C Medications

Hepatitis C Cures: New Drugs and Treatment Discussed   Hepatitis C can now be cured. There are new FDA approved medicines to treat hepatitis C with over a 95% cure rate. Dr. Joseph Galati... Monday HCV News Ticker- Hepatitis C: Coffee, M...
by HCV New Drug Research on Jul 13, 2016

Epclusa among hepatitis drugs that are medical miracles of the 21st century

Dr. Bill Elliott: Epclusa among hepatitis drugs that are medical miracles of the 21st century Last week the Food and Drug Administration approved a new drug to treat hepatitis C. The approval did... Monday HCV News Ticker- Hepatitis C: Coffee, Medi...
by HCV New Drug Research on Jul 11, 2016

Listen: Hep C Buyers Club

Radio New Zealand From Jesse Mulligan, 1–4pm This story was broadcast on Monday 11 July 2016 Hep C Buyers Club 1:27 pm on 11 July 2016 Hazel Heal has suffered from Hepatitis C for about 30 years,... Monday HCV News Ticker- Hepatitis C: Coffee, M...
by HCV New Drug Research on Jul 11, 2016

Listen: Hep C Buyers Club

Radio New Zealand From Jesse Mulligan, 1–4pm This story was broadcast on Monday 11 July 2016 Hep C Buyers Club 1:27 pm on 11 July 2016 Hazel Heal has suffered from Hepatitis C for about 30 years,... Monday HCV News Ticker- Hepatitis C: Coffee, M...
by HCV New Drug Research on Jul 11, 2016

Watch - New Opportunities and Challenges in Hepatitis C

New Opportunities and Challenges in Hepatitis C The American Journal of Managed Care Hepatitis C is an enormously common disease that is often initially asymptomatic. New drugs are very effective,... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jul 11, 2016

Gilead's Epclusa® - European Commission Grants Marketing Authorization

European Commission Grants Marketing Authorization for Gilead's Epclusa® (Sofosbuvir/Velpatasvir) for the Treatment of All Genotypes of Chronic Hepatitis C Date(s): 8-Jul-2016 6:51 AM - Epclusa is... Monday HCV News Ticker- Hepatitis C: Coffee, M...
by HCV New Drug Research on Jul 8, 2016

Velpatasvir/Sofosbuvir Makes HCV Treatment Simpler, Especially For Genotypes 2 and 3

Medical News | Physician's First Watch July 6, 2016 From the Blogs: Easier Hepatitis C Treatment Take a look at what the NEJM Journal Watch bloggers are talking about right now: HIV and ID... Monday HCV News Ticker- Hepatitis C: Coffee, Medicare,...
by HCV New Drug Research on Jul 7, 2016

HCV Guidelines Update: Reflect Recent Approval of Epclusa (Sofosbuvir/Velpatasvir)

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C The American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA)... Monday HCV News Ticker- Hepatitis C: Coffee, Medi...
by HCV New Drug Research on Jul 7, 2016

Help with the high cost of hepatitis C drugs

Help with the high cost of hepatitis C drugs Judith Graham, Kaiser Health News After legal battles and lobbying efforts, thousands of people with hepatitis C are gaining earlier access to expensive... Monday HCV News Ticker- Hepatitis C: Coffee, Me...
by HCV New Drug Research on Jul 2, 2016

FDA Approved Gilead's Epclusa® (Sofosbuvir/Velpatasvir) to treat Genotype 1-6

As a quick reference click the links following Gilead's press release for study results (full text) from ASTRAL 1-4 clinical trials. Prescribing Information: EPCLUSA News and Updates:... Monday HCV News Ticker- Hepatitis C: Coffee, Medic...
by HCV New Drug Research on Jun 28, 2016

Kiwis chase overseas drugs to help battle Hepatitis C

Kiwis chase overseas drugs to help battle Hepatitis C CATE BROUGHTON Last updated 05:00, June 18 2016 50,000 people have Hep C in New Zealand, but a recent Pharmac announcement about funding for... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jun 17, 2016

New Combination Therapy May Be Effective Against Chronic HCV Infection

New Combination Therapy May Be Effective Against Chronic HCV Infection By Will Boggs MD June 14, 2016 NEW YORK (Reuters Health) - The new NS3/4A protease inhibitor GS-9857, in combination with... Monday HCV News Ticker- Hepatitis C: Coffee, Medicar...
by HCV New Drug Research on Jun 15, 2016

Making Hepatitis C A Rare Disease In The United States

Making Hepatitis C A Rare Disease In The United States Victor Roy, Dave Chokshi, Stephen Kissler, and Prabhjot Singh New breakthrough medicines for Hepatitis C present an important choice about... Monday HCV News Ticker- Hepatitis C: Coffee, Medicar...
by HCV New Drug Research on Jun 15, 2016

Hep C sufferers angered by activist website ban - fixhepc website will be geoblocked

A website which raises awareness about a medical cure for hepatitis C could be hidden from Australians. 11:09pm, Jun 14, 2016 Richard Woolveridge Hepatitis C patients are angry and perplexed that... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jun 14, 2016

Ireland: HSE to expand hepatitis C treatment programme

HSE to expand hepatitis C treatment programme Paul Cullen, Sorcha Pollak An estimated 20,000 to 50,000 people in Ireland chronically infected with the disease Anti-viral drugs that can cure... Monday HCV News Ticker- Hepatitis C: Coffee, Medicare,...
by HCV New Drug Research on Jun 14, 2016


Trending Topics

Close